In the present study, we used a mouse model of Alzheimer's disease (AD) (3×Tg-AD mice) to longitudinally analyse the expression level of PDIA3, a protein disulfide isomerase and endoplasmic reticulum (ER) chaperone, in selected brain limbic areas strongly affected by AD-pathology (amygdala, entorhinal cortex, dorsal and ventral hippocampus). Our results suggest that, while in Non-Tg mice PDIA3 levels gradually reduce with aging in all brain regions analyzed, 3×Tg-AD mice showed an age-dependent increase in PDIA3 levels in the amygdala, entorhinal cortex, and ventral hippocampus. A significant reduction of PDIA3 was observed in 3×Tg-AD mice already at 6 months of age, as compared to age-matched Non-Tg mice. A comparative immunohistochemistry analysis performed on 3×Tg-AD mice at 6 (mild AD-like pathology) and 18 (severe AD-like pathology) months of age showed a direct correlation between the cellular level of Aβ and PDIA3 proteins in all the brain regions analysed, even if with different magnitudes. Additionally, an immunohistochemistry analysis showed the presence of PDIA3 in all post-mitotic neurons and astrocytes. Overall, altered PDIA3 levels appear to be age- and/or pathology-dependent, corroborating the ER chaperone's involvement in AD pathology, and supporting the PDIA3 protein as a potential novel therapeutic target for the treatment of AD.

PDIA3 expression is altered in the limbic brain regions of triple-transgenic mouse model of Alzheimer's disease / Cassano, Tommaso; Giamogante, Flavia; Calcagnini, Silvio; Romano, Adele; Lavecchia, Angelo Michele; Inglese, Francesca; Paglia, Giuliano; Bukke, Vidyasagar Naik; Romano, Antonino Davide; Friuli, Marzia; Altieri, Fabio; Gaetani, Silvana. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1422-0067. - 24:3(2023), p. 3005. [10.3390/ijms24033005]

PDIA3 expression is altered in the limbic brain regions of triple-transgenic mouse model of Alzheimer's disease

Giamogante, Flavia;Calcagnini, Silvio;Romano, Adele;Lavecchia, Angelo Michele;Paglia, Giuliano;Friuli, Marzia;Altieri, Fabio
;
Gaetani, Silvana
2023

Abstract

In the present study, we used a mouse model of Alzheimer's disease (AD) (3×Tg-AD mice) to longitudinally analyse the expression level of PDIA3, a protein disulfide isomerase and endoplasmic reticulum (ER) chaperone, in selected brain limbic areas strongly affected by AD-pathology (amygdala, entorhinal cortex, dorsal and ventral hippocampus). Our results suggest that, while in Non-Tg mice PDIA3 levels gradually reduce with aging in all brain regions analyzed, 3×Tg-AD mice showed an age-dependent increase in PDIA3 levels in the amygdala, entorhinal cortex, and ventral hippocampus. A significant reduction of PDIA3 was observed in 3×Tg-AD mice already at 6 months of age, as compared to age-matched Non-Tg mice. A comparative immunohistochemistry analysis performed on 3×Tg-AD mice at 6 (mild AD-like pathology) and 18 (severe AD-like pathology) months of age showed a direct correlation between the cellular level of Aβ and PDIA3 proteins in all the brain regions analysed, even if with different magnitudes. Additionally, an immunohistochemistry analysis showed the presence of PDIA3 in all post-mitotic neurons and astrocytes. Overall, altered PDIA3 levels appear to be age- and/or pathology-dependent, corroborating the ER chaperone's involvement in AD pathology, and supporting the PDIA3 protein as a potential novel therapeutic target for the treatment of AD.
2023
3×Tg-AD mice; Alzheimer’s disease; ageing; chaperone; disulfide isomerase isoform A3; limbic brain regions; longitudinal study; neuroinflammation; β-amyloid
01 Pubblicazione su rivista::01a Articolo in rivista
PDIA3 expression is altered in the limbic brain regions of triple-transgenic mouse model of Alzheimer's disease / Cassano, Tommaso; Giamogante, Flavia; Calcagnini, Silvio; Romano, Adele; Lavecchia, Angelo Michele; Inglese, Francesca; Paglia, Giuliano; Bukke, Vidyasagar Naik; Romano, Antonino Davide; Friuli, Marzia; Altieri, Fabio; Gaetani, Silvana. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1422-0067. - 24:3(2023), p. 3005. [10.3390/ijms24033005]
File allegati a questo prodotto
File Dimensione Formato  
Cassano_PDIA3 Expression_2023.pdf.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 4.13 MB
Formato Adobe PDF
4.13 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1669239
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact